Data were analyzed using the non-parametric Mann-Whitney U test for comparing two groups. Results-Spontaneously seroconversion of HBsAg was observed within

3-5months of acute infection and patients showed anti-HBs titers in the range of (12 -1000mIU/ml).TFH cells were significantly increased in Gr B compared to Gr. A (43.3 %vs. 34.7%,P=0.01 ).There was HBV specific functional impairment of TFH1 & 17 cells in Gr. B compared to Gr.A patients.The peptide stimulation of TFH cells in Gr.A compared to B showed significantly increased frequencies of CD4+CXCR5+CCR6+TNFα+ and IL17+ cells producing proinflammatory cytokines,TNF-α (8.96 %vs. 1.29%,p=0.02) and IL-17A(15 %vs 1.37%, p=0.014).Conclu-sions: Significantly increased IL-17A and TNF-alpha production by CD4+CXCR5+CCR6+ TFH-17 cells may play a major role in HBV clearance and HBsAg seroconversion. Freq. of cytokine

secreting TFH cells after HBC peptide stimulations (A) Freq. of TFH click here – TNF-A producing cells (B) Freq. of TFH-17-TNF-A producing cells, (C) Freq. of TFH-17- IL-17 producing cells in CHBV infected and HBsAg spontaneous Cleared patients. Disclosures: The following people have nothing to disclose: Ashish Vyas, Nivolumab purchase Shreya Sharma, Arshi Khanam, Ankit Bhardwaj, Nirupma Trehanpati, Shiv K. Sarin Background and aims: The interplay between HBV and host immunity plays a key role for clinical outcome of HBV infection. The study aimed to investigate clinical relevance of HBV mutations on epitopes of cytoxic T lymphocytes (CTL) and the impact of the mutations on CTL response. Methods: Sequence analysis of complete HBV genomes was performed for 516 HBV-infected patients with different clinical presentations. Among them, 188 HLA-A2-positive patients with genotype C HBV infection were further studied, including 51 with acute hepatitis B (AHB), 86 with chronic hepatitis B (CHB), and 51 with acute-on-chronic liver failure (ACLF). The mutations at 31 known HLA-A2-resticted epitopes were analyzed. Binding affinity of epitopic peptides

Cobimetinib concentration were estimated by BIMAS and measured by T2 cell binding assay. S-gene vaccines containing wild-type or mutant env183-191 epitope-encoding sequence were constructed and inoculated into HLA-A2/HBV transgenic mice. The epitope-specific CD8 T cells were detected by pen-tamers, IFN-γ ELISPOT, and cytotoxicity assay. Results: The incidences of 12 HLA-A2-restricted epitopic mutations were significantly different among ACLF, CHB and AHB patients. BIMAS scores significantly reduced for 10 mutant epitopes and increased for 2 mutant epitopes compared to the wild-type. T2 cell binding assay verified the affinity change of the mutant epitopes. env183-191 (FLLTRILTI) had three mutational patterns, i.e., FLLTKILTI (K), FSLTRILTI (S), and FSLTKILTI (SK). The K, S, and SK mutation incidences were 11.8%, 0%, and 0 %in AHB patients; 1.2%, 16.3%, and 0 %in CHB patients; and 15.7%, 11.8%, and 9.8 %in ACLF patients.